- Home
- RGEN vs WYNN Comparison
RGEN vs WYNN Comparison
Compare RGEN & WYNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGEN
- WYNN
- Stock Information
- Founded
- RGEN 1981
- WYNN 2002
- Country
- RGEN United States
- WYNN United States
- Employees
- RGEN N/A
- WYNN N/A
- Industry
- RGEN Medical/Dental Instruments
- WYNN Hotels/Resorts
- Sector
- RGEN Health Care
- WYNN Consumer Discretionary
- Exchange
- RGEN Nasdaq
- WYNN Nasdaq
- Market Cap
- RGEN 8.0B
- WYNN 8.7B
- IPO Year
- RGEN N/A
- WYNN 2002
- Fundamental
- Price
- RGEN $118.07
- WYNN $90.54
- Analyst Decision
- RGEN Buy
- WYNN Strong Buy
- Analyst Count
- RGEN 12
- WYNN 12
- Target Price
- RGEN $172.67
- WYNN $115.50
- AVG Volume (30 Days)
- RGEN 791.0K
- WYNN 2.7M
- Earning Date
- RGEN 04-29-2025
- WYNN 05-06-2025
- Dividend Yield
- RGEN N/A
- WYNN 1.10%
- EPS Growth
- RGEN N/A
- WYNN N/A
- EPS
- RGEN N/A
- WYNN 3.75
- Revenue
- RGEN $650,429,000.00
- WYNN $6,965,449,000.00
- Revenue This Year
- RGEN $13.93
- WYNN $0.08
- Revenue Next Year
- RGEN $14.35
- WYNN $3.18
- P/E Ratio
- RGEN N/A
- WYNN $24.14
- Revenue Growth
- RGEN 4.88
- WYNN N/A
- 52 Week Low
- RGEN $102.97
- WYNN $65.25
- 52 Week High
- RGEN $182.52
- WYNN $107.81
- Technical
- Relative Strength Index (RSI)
- RGEN 39.80
- WYNN 54.86
- Support Level
- RGEN $120.55
- WYNN $89.06
- Resistance Level
- RGEN $123.71
- WYNN $93.16
- Average True Range (ATR)
- RGEN 4.63
- WYNN 2.21
- MACD
- RGEN -0.58
- WYNN -0.72
- Stochastic Oscillator
- RGEN 7.59
- WYNN 16.46
About RGEN Repligen Corporation
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.
About WYNN Wynn Resorts Limited Common stock
Wynn Resorts operates luxury casinos and resorts. The company was founded in 2002 by Steve Wynn, the former CEO. The company operates four megaresorts: Wynn Macau and Encore in Macao and Wynn Las Vegas and Encore in Las Vegas. Cotai Palace opened in August 2016 in Macao, and Encore Boston Harbor in Massachusetts opened June 2019. We expect the company to continue to build nongaming attractions in Macao over the next few years. We model Wynn's managed integrated resort in the United Arab Emirates to open in 2027. The company also operates Wynn Interactive, a digital sports betting and iGaming platform. The company received 76% and 24% of its 2019 prepandemic EBITDA from Macao and the US, respectively. In 2024, both the US and Macao were each 50% of total EBITDA.